Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Doximity ( (DOCS) ) just unveiled an announcement.
On August 28, 2025, Doximity, Inc. held its Annual Meeting of Stockholders where three key proposals were voted on. The stockholders elected two directors, ratified Deloitte & Touche LLP as the accounting firm for the fiscal year ending March 31, 2026, and approved, on a non-binding basis, the compensation of the company’s named executive officers for the fiscal year ended March 31, 2025. These decisions reflect the company’s ongoing governance and operational strategies, potentially impacting its future financial and strategic direction.
The most recent analyst rating on (DOCS) stock is a Buy with a $79.00 price target. To see the full list of analyst forecasts on Doximity stock, see the DOCS Stock Forecast page.
Spark’s Take on DOCS Stock
According to Spark, TipRanks’ AI Analyst, DOCS is a Outperform.
Doximity’s overall stock score is driven by its strong financial performance and positive earnings call, which highlight robust growth and strategic advancements in AI. While technical indicators show a positive trend, the high P/E ratio suggests potential overvaluation, slightly tempering the overall score.
To see Spark’s full report on DOCS stock, click here.
More about Doximity
Doximity, Inc. operates in the healthcare technology industry, providing a professional network for medical professionals. The company’s primary services include a digital platform that enables healthcare professionals to collaborate, share insights, and access specialized content, with a focus on enhancing communication and efficiency within the medical community.
Average Trading Volume: 1,807,877
Technical Sentiment Signal: Buy
Current Market Cap: $12.73B
Learn more about DOCS stock on TipRanks’ Stock Analysis page.